EILEEN DONNELLY: Open Payments
NPI 1336659010 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 9 payments from 6 companies in 2025. Trend: 2023 $231 · 2024 $310 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| ABBVIE INC. | 1 | $26 |
| Alkermes, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, FANAPT, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
